In the obesity model we have tested activity of the new selective antagonist of A2A adenosine receptor—compound KD-64 and compared its effect to the known non-selective antagonist of adenosine receptors—caffeine. Here, ADORA2A is linked to obesity due to melanocortin 4 receptor deficiency.